AGILENT TECHNOLOGIES, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $A in the last 30 days.
See all $A insider activity →SK pharmteco plans a $200M US expansion for peptide and small-molecule production, adding 100 jobs. Flamma Group acquires an API plant in Italy from Lundbeck. Agilent completes a $725M investment in oligonucleotide manufacturing. Sterling Pharma doubles bioconjugation capacity in Wales. Hovione opens a US facility for spray drying drug ingredients.
Agilent Technologies launched NovoStation, an automated sample prep system. The company claims it reduces hands-on time in flow cytometry workflows by over 90% in validation studies. Agilent aims to expand its end-to-end flow cytometry workflow and automation capabilities.
Agilent Technologies (NYSE: A) launched the Gen5 AI cell identification module for BioTek automated cell imagers, a new image analysis tool. The company specializes in life sciences, diagnostics, and applied chemical markets.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning A (AGILENT TECHNOLOGIES, INC.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent A coverage spans corporate actions, sector analysis and technology.
Agilent could benefit from rising demand for oligonucleotide therapeutics.
The new product expands Agilent's automation portfolio and could drive incremental revenue from life‑science customers.
The new AI module could boost Agilent's revenue from life-science instrumentation.
Analyst upgrade and higher target may generate modest buying pressure.
No new catalyst; price move likely continuation of prior momentum.
AlphAI scores every news story that mentions A with an AI model for sentiment and relevance, and aggregates insider trades from AGILENT TECHNOLOGIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
SK pharmteco plans a $200M US expansion for peptide and small-molecule production, adding 100 jobs. Flamma Group acquires an API plant in Italy from Lundbeck. Agilent completes a $725M investment in oligonucleotide manufacturing. Sterling Pharma doubles bioconjugation capacity in Wales. Hovione opens a US facility for spray drying drug ingredients.
2 min readAgilent Technologies launched NovoStation, an automated sample prep system. The company claims it reduces hands-on time in flow cytometry workflows by over 90% in validation studies. Agilent aims to expand its end-to-end flow cytometry workflow and automation capabilities.
1 min readAgilent Technologies (NYSE: A) launched the Gen5 AI cell identification module for BioTek automated cell imagers, a new image analysis tool. The company specializes in life sciences, diagnostics, and applied chemical markets.
1 min readAnalysts Eve Burstein (Bernstein) and Chris Schott (J.P. Morgan) maintained Buy ratings on Agilent (A) and Regeneron (REGN) with price targets of $180 and $900, respectively. Agilent's consensus target is $177.87 (3.4% upside), while Regeneron's is $843.47 (4.9% upside). Both stocks have Strong Buy/Moderate Buy consensus ratings.
2 min readAgilent Technologies (A) stock rose 3.4% today, potentially due to its strong Q3 2026 earnings report, raised full-year outlook, and recent product launches. The company reported $1.88B in revenue, up 8.1% YoY, and announced a new dividend.
2 min readAgilent Technologies (A) launched the S540MD slide scanner in the U.S., capable of holding 540 slides, targeting high-volume pathology labs. The scanner has FDA clearance and integrates with existing lab setups. Agilent reported Q3 revenue of $1.88B, up 8.1% YoY, and raised full-year non-GAAP EPS guidance to $6.18-$6.21. The scanner is a rebadged Hamamatsu model, with no pricing or revenue estimates provided.
3 min readAgilent Technologies maintained its quarterly dividend at $0.255 per share. The company's stock has seen a 5-day change of 2.28%, a 1st Jan change of 4.66%, and a 12.95% increase overall. This follows a recent downgrade by UBS.
1 min readAgilent Technologies (NYSE:A) declared a quarterly dividend of $0.255 per share, payable October 6, 2026, to shareholders of record by October 28, 2026. The company noted future dividends depend on board approval. Agilent reported $6.95B revenue in fiscal 2025.
1 min readAGILENT TECHNOLOGIES, INC. (A) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors SANTA CLARA, Calif., Sept. 8, 2026 — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of di
2 min readAgilent Technologies (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting an upward trend in earnings estimates. The Zacks rating system, which is based on earnings estimate revisions, suggests a positive outlook for the company's stock price. Analysts have raised their estimates for Agilent by 3.4% over the past three months, with the company expected to earn $6.17 per share for the fiscal year ending October 2026.
2 min read
